ASKA Pharmaceutical Holdings Co.,Ltd. (TSE: 4886)
Health Care · Pharmaceuticals · JP
¥2,004.00
-1.28% today · -6.6% 1Y
ASKA Pharmaceutical Holdings Co.,Ltd. (TSE: 4886) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $359.39M and employs 1,611 people.
Over the last twelve months the share price has lost 6.6%, trading between 1.92K and 3.04K.
Tweenvest scores ASKA Pharmaceutical Holdings Co.,Ltd. across four factors: quality 77/100, value 41/100, growth 12/100, dividend 60/100. Its strongest factor is quality.
4886 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $359.39M
- Revenue (TTM)
- $436.00M
- P/E
- 12.10
- EPS
- 165.62
- Dividend yield
- 3.24%
- Beta (5Y)
- 0.47
- 52-week high
- ¥3,045.00
- 52-week low
- ¥1,917.00
- Avg volume (3M)
- —
- Shares outstanding
- 28.40M
- Employees
- 1,611
- Next earnings
- —
About ASKA Pharmaceutical Holdings Co.,Ltd.
ASKA Pharmaceutical Holdings Co.,Ltd. is a Japanese enterprise that operates through its subsidiaries in three primary areas: pharmaceuticals, animal healthcare, and hormone testing services. The company's pharmaceutical division is dedicated to the research, development, production, and commercialization of medications, with a specific focus on endocrinology, obstetrics and gynecology, and urology. Within its animal health segment, ASKA manufactures, sells, imports, and exports a broad spectrum of veterinary products, such as medicines, medical equipment, animal feed and supplements, laboratory reagents, agricultural chemicals, industrial chemicals, hygiene products, and food items along with their raw materials. Beyond these activities, the company also performs clinical and biological testing and offers medical devices. Founded in 1920, ASKA Pharmaceutical Holdings Co.,Ltd. is headquartered in Tokyo, Japan.
- ISIN
- JP3119660003
- Founded
- 1920
- Listed since
- Apr 1, 2021
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Egyptian International Pharmaceutical Industries CompanyCASE: PHAR | $367.68M | EGP114.10 | -1.47% |
| GlaxoSmithKline Pakistan LimitedKASE: GLAXO | $364.11M | PKRs316.60 | +1.20% |
| Zhejiang Xinguang Pharmaceutical Co., Ltd.SZSE: 300519 | $362.13M | CN¥15.16 | +2.29% |
| Relmada Therapeutics, Inc.NasdaqCM: RLMD | $361.61M | $3.45 | +1.62% |
| Suzhou Fushilai Pharmaceutical Co., Ltd.SZSE: 301258 | $357.63M | CN¥27.04 | -1.31% |
| Turn Therapeutics Inc.NasdaqGM: TTRX | $357.46M | $11.48 | -4.33% |
| ShanXi C&Y Pharmaceutical Group Co.,LTD.SZSE: 300254 | $356.35M | CN¥9.28 | +0.98% |
| Qinghai Spring Medicinal Resources Technology Co., Ltd.SHSE: 600381 | $352.91M | CN¥4.13 | -1.67% |
Figures last refreshed Oct 11, 2026.